Type B Aortic Dissection Clinical Trial
Prospective, single-arm, multi-center registry study A total of 50 subjects with Type B
aortic dissection who meet all inclusion and exclusion criteria will be included.
Patients will be treated with TEVAR using conformable TAG endograft (Gore). Patients will be
followed clinically for 12 months after the procedure. CT will be performed at 12 months.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01984905 -
Study of Prognostic Factors in Aortic Dissection Type B
|
N/A | |
Completed |
NCT00908388 -
Evaluation of the GORE Conformable TAG® Thoracic Endoprosthesis for Treatment of Acute Complicated Type B Aortic Dissection
|
N/A | |
Recruiting |
NCT05479305 -
Evaluation of the Valiant Captivia Physician Fenestrated Stent Graft System in Aortic Arch and Descending Thoracic Aorta Pathologies
|
N/A | |
Completed |
NCT01407159 -
A Study in SurvIvors of Type B Aortic Dissection Undergoing Stenting
|
N/A | |
Not yet recruiting |
NCT05349071 -
PreOperative Methylprednisolone on Thoracic Endovascular Repair for Reducing Post-implantation Syndrome (POMTEVAR)
|
N/A | |
Not yet recruiting |
NCT06289777 -
Aortic Remodeling After Endovascular Management of Type B Aortic Dissection.
|
||
Enrolling by invitation |
NCT03845829 -
LSA Reconstruction With Laser Fenestration During the TEVAR
|
N/A | |
Recruiting |
NCT06418828 -
Patients With Type B Aortic Dissection Returning to Work After Dischargeļ¼a Cross-sectional Survey
|
||
Active, not recruiting |
NCT04765605 -
Guo's Subclavian Artery Reconstruction: The Prospective, Multiple Center Study of WeFlow-Tbranch Stent Graft System(GUEST Study)
|
N/A | |
Recruiting |
NCT06087029 -
IMPRoving Outcomes in Vascular DisEase- Aortic Dissection
|
N/A |